StreetInsider.com News Articles

ENvue Medical secures $50M equity facility for growth and acquisitions

Wed, 12 Aug 2026 08:36:18 -0400

ENvue Medical, Inc. (NASDAQ: FEED) announced it has entered into a securities purchase agreement with an institutional investor providing an equity facility of up to $50 million, subject to terms including stockholder approval.

The Tyler, Texas-based medical technology company said the facility is intended to support expansion of its technology platform and evaluation of strategic acquisitions and business development opportunities.

"We have a strong foundation in enteral navigation and a technology roadmap that we believe can take us further," said Doron Besser, CEO of ENvue Medical. "With greater financial flexibility, we believe we will be able to evaluate opportunities to acquire technologies,

ENvue Medical secures $50M equity facility for growth and acquisitions

Wed, 12 Aug 2026 08:36:18 -0400

ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions

Wed, 12 Aug 2026 08:35:00 -0400

TYLER, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that it has entered into a securities purchase agreement (“ELOC”) with an institutional investor providing the Company with an equity facility for up to $50 million in capital (the “Facility”), subject to the terms and conditions of the agreement, including the receipt of stockholder approval.

The facility strengthens ENvue’s financial flexibility and supports the Company’s plans to advance its next-generation technology platform and evaluate selective strategic acquisition and business development opportunities.

ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions

Wed, 12 Aug 2026 08:35:00 -0400

ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions

Wed, 12 Aug 2026 08:35:00 -0400

ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions

Wed, 12 Aug 2026 08:35:00 -0400

Form 8-K ENvue Medical, Inc. For: Aug 12

Wed, 12 Aug 2026 08:30:00 -0400

si-local-file:///var/storage/secattach/20260812/26909414.html

Form 8-K ENvue Medical, Inc. For: Aug 12

Wed, 12 Aug 2026 08:30:00 -0400

si-local-file:///var/storage/secattach/20260812/26909414.html

Envue (FEED) files $50M mixed shelf

Mon, 10 Aug 2026 16:21:06 -0400

Envue (NASDAQ: FEED) filed $50,000,000 mixed shelf of:

COMMON STOCK

WARRANTS

UNITS

Envue (FEED) files $50M mixed shelf

Mon, 10 Aug 2026 16:21:06 -0400

Envue (NASDAQ: FEED) filed $50,000,000 mixed shelf of:

COMMON STOCK

WARRANTS

UNITS

Form S-3 ENvue Medical, Inc.

Mon, 10 Aug 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260810/26898229.html

Form S-3 ENvue Medical, Inc.

Mon, 10 Aug 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260810/26898229.html

ENvue Medical moves NanoVibronix manufacturing to the U.S.

Tue, 04 Aug 2026 09:02:45 -0400

ENvue Medical, Inc. (NASDAQ: FEED) has completed the transfer of its NanoVibronix manufacturing operations from Israel to the United States, while consolidating its research and development activities in Tel Aviv, Israel, according to a statement from the company.

The NanoVibronix product line includes PainShield® and UroShield®, acoustic-based therapeutic devices that use low-intensity surface acoustic wave (SAW) technology and are designed for home or care settings.

Doron Besser, MD, CEO of ENvue Medical, said the transition is intended to "improve operational efficiency, reduce costs, and streamline supply chain management, while enhancing operational oversight."

The Tyler, Texas-based company said the move is part of a

ENvue Medical moves NanoVibronix manufacturing to the U.S.

Tue, 04 Aug 2026 09:00:52 -0400

ENvue Medical, Inc. (NASDAQ: FEED) announced it has completed the transfer of its NanoVibronix manufacturing operations from Israel to the United States, while consolidating its research and development activities in Tel Aviv, Israel.

The company, headquartered in Tyler, Texas, said the operational changes are part of a broader effort to reduce operating expenses and improve its cost structure.

"Completing the transition of our NanoVibronix product line manufacturing to the United States marks the achievement of a major strategic operational initiative for the Company," said Doron Besser, MD, CEO of ENvue Medical. "By consolidating our manufacturing operations domestically, we expect to improve operational

ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities